10 studies on AMPK mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This study provides compelling preclinical evidence that semaglutide, a widely used GLP-1 receptor agonist for type 2 diabetes and obesity, possesses significant neuroprotective properties against chemotherapy-induced…
This comprehensive review underscores the immense potential of novel drug targets, innovative drug classes, and cutting-edge technologies to revolutionize the treatment landscape for metabolic diseases. The insights g…
If successful, this trial could identify a novel dietary supplement, AMPK Charge+®, that effectively improves glycemic control in individuals with prediabetes or Type 2 Diabetes. The potential for AMPK Charge+® to enh…
Understanding metformin's brain-mediated actions represents a critical advancement, opening entirely new avenues for optimizing existing T2D treatment strategies and developing innovative therapies. This deeper mechan…
These findings are highly significant as they demonstrate that Ghrelin acts as a potent neuroprotective agent against HIE-induced brain injury by modulating oxidative stress and neuronal apoptosis. The elucidation of …
This research highlights the CeA as a pivotal hub for integrating metabolic information via AMPK, offering a novel understanding of appetite regulation. The identification of AMPK in the CeA as a sensitive target for …
This study identifies MOTS-c as a promising novel therapeutic agent for cancer-induced bone pain, addressing a significant unmet medical need in oncology. Its unique mechanism through AMPK-mediated mitochondrial bioge…
This research provides a novel mechanistic understanding of how endurance training improves skeletal muscle mitochondrial function, highlighting MOTS-c as a key player. The findings suggest that circulating MOTS-c lev…
This research highlights MOTS-c as a promising novel therapeutic agent for preventing or treating CPB-induced acute lung injury. By promoting glycolysis through the AMPK-HIF-1α-PFKFB3 pathway, MOTS-c offers a unique m…
This research highlights MOTS-c as a potent activator of muscle mitochondrial function, offering a novel therapeutic strategy for conditions characterized by mitochondrial dysfunction and muscle decline. By improving …